Archives

Real-World Effectiveness of Fecal Microbiota, live-jslm for the Prevention of Recurrent Clostridioides difficile Infection

Oct 17, 2024 | New Therapies & Programs

Presented at IDWeek 2024 Authors: Richard L. Hengel, MD Sujatha Krishan, MD Timothy E. Ritter, MD Jonathan A. Rosenberg, MD Kathy A. Baker Ph.D., APRN Lucinda J. Van Anglen, PharmD Kelly E. Hanna, PharmD Amy Guo, PhD Mielad Moosapanah, PharmD Sanghyuk Seo, PharmD, MS...

Infectious Disease Physician Office-Based HIV Program Results in Successful Adherence of Therapy in Patients Receiving Long-Acting Cabotegravir and Rilpivirine

Oct 17, 2024 | New Therapies & Programs

Presented at IDWeek 2024 Authors: Nikhil K. Bhayani, MD, FIDSA Jorge R. Bernett, MD Thomas K. Sleweon, MD Erika M. Young, DO Kent J. Stock, DO Stacey E. Baker, MD Quyen Luu, MD Brian S. Metzger, MD, MPH Kimberly A. Couch, PharmD, MA, FIDSA, FASHP Christina J. Weeks,...

Real-World Experience with Microbiota Treatment for the Prevention of Recurrent Clostridioides difficile Infection

Oct 28, 2024 | New Therapies & Programs

Presented at ACG 2024 Authors: Timothy E. Ritter, MD Jonathan A. Rosenberg, MD Richard L. Hengel MD Sujatha Krishan, MD Kathy A. Baker Ph.D., APRN Lucinda J. Van Anglen, PharmD Kelly E. Hanna, PharmD Amy Guo, PhD Mielad Moosapanah, PharmD Sanghyuk Seo, PharmD, MS...